FDA product code CEC: Radioimmunoassay, Free Thyroxine
CEC is the FDA product code for radioimmunoassay, free thyroxine. It is a Class II device, regulated under 21 CFR 862.1695 and reviewed by the Clinical Chemistry panel. FDA has cleared 92 510(k) submissions under CEC, 2 in the last five years, from 57 different applicants. The average 510(k) review took 104 days (median 71); 35 days on average over the last three years. FDA has posted 12 recalls for CEC devices.
Classification
| Field | Value |
|---|---|
| Device name | Radioimmunoassay, Free Thyroxine |
| Device class | Class II |
| Regulation | 21 CFR 862.1695 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for CEC
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 28 |
| 2018 | 2 | 80 |
| 2023 | 1 | 414 |
| 2024 | 1 | 35 |
Compare with all 510(k) review times · Search every CEC clearance
Top CEC applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Abbott Laboratories | 8 | 2017-10-27 |
| Bd Becton Dickinson Vacutainer Systems Preanalytic | 8 | 1993-04-20 |
| Amersham Corp. | 5 | 1989-08-03 |
| Siemens Healthcare Diagnostics, Inc. | 4 | 2014-11-26 |
| Roche Diagnostics | 3 | 2023-04-07 |
52 more applicants have CEC clearances. See the full list in Caduvo.
Most recent CEC clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K240273 | Beckman Coulter, Inc. | Access Free T4 | 2024-03-06 | 35 |
| K220456 | Roche Diagnostics | Elecsys FT4 IV | 2023-04-07 | 414 |
| K182423 | Shenzhen New Industries Biomedical Engineering Co., Ltd. | MAGLUMI 2000 FT4 | 2018-10-04 | 28 |
| K181233 | Roche Diagnostics | Elecsys FT4 III | 2018-09-18 | 132 |
| K173122 | Abbott Laboratories | Abbott Architect Free T4 | 2017-10-27 | 28 |
Recalls for CEC devices
12 product recalls in 10 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2019-04-30.
| Year | Recalls |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
Frequently asked questions
What is FDA product code CEC?
CEC is the FDA product code for radioimmunoassay, free thyroxine. It is a Class II device, regulated under 21 CFR 862.1695 and reviewed by the Clinical Chemistry panel.
What device class is CEC?
Class II, regulation 21 CFR 862.1695. Typical premarket route: 510(k).
How long does a 510(k) take for product code CEC?
Across 92 cleared submissions the average was 104 days from receipt to decision (median 71).
Which companies have the most CEC clearances?
Abbott Laboratories (8); Bd Becton Dickinson Vacutainer Systems Preanalytic (8); Amersham Corp. (5); Siemens Healthcare Diagnostics, Inc. (4); Roche Diagnostics (3).
Have CEC devices been recalled?
Yes: 12 product recalls across 10 recall events; the most recent began 2019-04-30.
Next steps
- Run an FDA pathway report with predicate devices for product code CEC
- Run a recall and safety report across every CEC manufacturer
- Watch product code CEC for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times